Covid outcomes by vaccination status

Primary outcomes of the study included the rate of SARS-CoV-2 vaccination and the incidence of disease flares after vaccination. Of the 914 adults (92.5% women; mean age, 48.6±14.0 years) with SLE included in the analysis, 449 (49.1%) achieved full COVID-19 vaccination status. The majority (61.5%) of participants received 2 doses of. Notably, Omicron was the dominant variant during the study period, accounting for 93% of 339 sequenced COVID-19 infections. This young, healthy, highly vaccinated NBA cohort was frequently monitored for COVID-19. The study showed that booster vaccinations significantly reduced COVID-19 infections during the Omicron wave. The side effects after vaccination were similar for both the bivalent vaccine and the original vaccine, and there were no safety issues observed. 6. The Health Sciences Authority and the Expert Committee on COVID-19 Vaccination have independently reviewed the data, and assessed that the bivalent Moderna/Spikevax vaccine has a similar safety profile as the. The aims of this research project were multiple: a) to present and highlight the outcomes of the vaccination against COVID-19; b) to show the widespread use of antibiotics during the initial admission and treatment of COVID-19 patients in out-of-hospital settings; c) to appeal to the healthcare system and government agencies to prevent such patterns in order to prevent an. In the United Kingdom, a study by Public Health England found that the risk of COVID‑19 among health care workers decreased by 65‑72% after the first dose of the Pfizer/BioNTech vaccine, and more than 85% after the second dose. Data.CDC.gov. Search Search . Home Data Catalog Developers Video Guides. Vaccination against Covid-19 reduces the risk of ... the same treatment or access to services resulting in different health outcomes. ... not had a fight about their respective vaccine status. Background: The objective of this study was to assess changes in social and clinical determinants of COVID-19 outcomes associated with the first year of COVID-19 vaccination rollout in the Basque population. Methods: A retrospective study was performed using the complete database of the Basque Health Service (n = 2,343,858). We analyzed data on age,. Today's report shows that in July unvaccinated individuals ages 5 and older had 18 times the risk of hospitalization and 47 times the risk of dying than individuals who were up-to-date on COVID-19 vaccinations. Vaccines. The COVID-19 vaccine is now available to all New York residents 6 months and older. The Health Department is closely monitoring the status of vaccinations in NYC, including the demographics and locations of people who have received the vaccine. The data below show how vaccinations in NYC have progressed since December 2020. COVID-19 vaccination. Modification date 09/20/2022 - 13:08. RIVM informs doctors and other care providers about the administration of the COVID-19 vaccinations in the Netherlands. Activities include arranging storage, transport and distribution of the vaccines, and keeping track of who received which vaccine. RIVM registers data about COVID-19. Stockton Campus 3601 Pacific Ave. Stockton, CA 95211 Admissions: 209.946.2211. Sacramento Campus 3200 Fifth Ave. Sacramento, California 95817 Admissions: 916.739.7105. Breakthrough disease occurs when a fully vaccinated person experiences symptoms of COVID-19 disease. Vaccines remain highly effective at preventing severe disease, breakthrough infections and disease among vaccinated individuals remain uncommon, and most of the new COVID-19 cases in the U.S. are among unvaccinated people. The COVID-19 application allows the public to explore data using several applications and reports. This story was last updated on Jan. 31, 2022. S cientific teams around the world have developed successful Covid-19 vaccines in incredibly short order. In a feat that even a couple of years ago. Vaccination Status in Arizonans 5 Years and Older • COVID-19 vaccines are safe and effective tools to bring the pandemic under control. • ADHS is working with CDC and local health departments to investigate SARS-CoV-2 infections among people who received COVID-19 vaccine to identify patterns or trends in patient characteristics, the. The estimates imply that 250 additional doses, with a marginal cost around $40000, leads to one expected life saved. This $40000 is far below typical estimates of the value of a statistical life. t. e. India began administration of COVID-19 vaccines on 16 January 2021. As of 1 August 2022, India has administered over 2.04 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines. [2] [3] In India, 94% of the eligible population (12+) has received at least one shot, and 86% of the. Tracking Coronavirus Vaccinations Around the World. By Josh Holder Updated Sept. 4, 2022. 69.7% of the global population. Received at least one dose. Received additional dose. Fully vaccinated. The proportion of patients with COVID-19 dying by age group and influenza vaccination status. Based on a sample of 40 394 cases with observed mortality outcomes. Estimates represent unadjusted linear differences in age group-specific mortality with 95% CIs. Table 2 shows results from the multivariable logistic regression analysis. TERAVOLT found reduced patient mortality with the most recent COVID surge. COVID vaccination with booster improved outcomes of hospitalization or death. Delays in cancer therapy remain an issue, which has the potential to worsen cancer-related mortality. CDC collaborates with more than 30 state and local health departments that routinely link case surveillance, immunization registry, and vital registration data to monitor. Before the COVID-19 pandemic, data on humoral and cellular immune response to antiviral vaccination in cancer patients was scarce, and mostly addressed the issue of influenza vaccination. 37, 38 In order to generate protective immunity following vaccination, intact host immunity is needed, particularly with respect to antigen presentation, B- and T-cell activation. Tracking cases of COVID-19 that occur after vaccination and/or boosters is important for monitoring the impact of immunization on the occurrence of COVID-19 infections, hospitalizations, and deaths. While COVID-19 vaccines are safe and effective, some cases are still expected in persons who have been vaccinated or boosted, as no vaccine is 100%. COVID-19 Cases and Deaths by Vaccination Status Dashboard Background To determine the effects of vaccination on COVID-19 cases and deaths in Texas, this dashboard describes COVID-19 outcomes among unvaccinated and vaccinated people in Texas using data from electronic lab reports, death certificates, and the state immunization registry. While pregnant women were first excluded from clinical trials for COVID-19 vaccines, observational data from many countries now show that COVID-19 vaccines don’t affect pregnancy outcomes. Pregnancy places someone at a higher risk of getting severe COVID-19, and the infection increases the risk of pregnancy complications, including perinatal death..

Thus, ensuring the successful uptake of COVID-19 vaccines globally requires a pragmatic, low burden assessment of stakeholders' perceptions of implementation outcomes related to vaccination (e.g., acceptability, cost) , as well as specific and operationalized implementation strategies to address barriers to vaccine uptake. On Nov. 9, 2020, New York-based Pfizer and the German company BioNTech made history by announcing that their coronavirus vaccine had an efficacy rate of over 90 percent, far surpassing. COVID-19 vaccines are free and widely available in Ontario. Visit Ontario.ca/bookvaccine to schedule an appointment at a clinic or pharmacy. Vaccination appointments are also available at the Kitchener – Doon campus for Conestoga students and employees. Book now. Pre. United States: COVID-19 weekly death rate by vaccinationstatus. Death rates are calculated as the number of deaths in each group, divided by the total number of people in this group. This is. Some patients are arriving at overwhelmed emergency rooms only to be transported hundreds of miles away for care. Others have suffered complications and even died waiting for beds in intensive care. Vaccines Are Still Mostly Blocking Severe Disease. Our original-recipe shots are holding up against new variants. But we may need to improve them, and soon. For the past year and a half, since the. The health effects of COVID-19 have disproportionately affected individuals belonging to low income and racially or ethnically minoritized groups. Studies have shown a higher number of COVID-19. The Ohio Vaccine Management Solution (VMS) offered by the Ohio Department of Health (ODH) is a website-based system to assist COVID-19 vaccine providers and patients with vaccine appointment scheduling and vaccine administration. This no-cost tool can assist providers with patient registration, scheduling, vaccine inventory, and clinic. Risk factors associated with severe COVID-19 outcomes after receiving a booster dose were similar to those associated with worse outcomes after completion of the primary vaccination schedule. There was an increased risk of severe COVID-19 outcomes 9 weeks or more after receiving a booster dose of BNT162b2 or mRNA-1273 vaccine (≥9 weeks vs 3–5. Risk factors associated with severe COVID-19 outcomes after receiving a booster dose were similar to those associated with worse outcomes after completion of the primary vaccination schedule. There was an increased risk of severe COVID-19 outcomes 9 weeks or more after receiving a booster dose of BNT162b2 or mRNA-1273 vaccine (≥9 weeks vs 3–5. This dataset reports the daily reported number of the 7-day moving average rates of Deaths involving COVID-19 by vaccination status and by age group. Learn how the Government. TERAVOLT found reduced patient mortality with the most recent COVID surge. COVID vaccination with booster improved outcomes of hospitalization or death. Delays in cancer therapy remain an issue, which has the potential to worsen cancer-related mortality. Common side effects of the COVID-19 vaccines include injection site pain, fatigue, headache, muscle pain and fever. Data from the Pfizer/BioNTech and Moderna trials also show the side effects.According to the CDC, anaphylaxis - a severe and possible life-threatening allergic reaction - occurs in 2 to 5 people per million vaccinated in the United States. Clinical phenotype and vaccination background of Omicron vs Delta-infected patients. Compared to patients infected with variant Delta, those infected with variant Omicron were older and had. COVID-19 Outcomes Achieved by the Vaccination Program: A Nationwide Cohort Study. Int. J ... sex, socioeconomic status, the Charlson comorbidity index (CCI), hospitalization and intensive care. Risk factors associated with severe COVID-19 outcomes after receiving a booster dose were similar to those associated with worse outcomes after completion of the primary vaccination schedule. There was an increased risk of severe COVID-19 outcomes 9 weeks or more after receiving a booster dose of BNT162b2 or mRNA-1273 vaccine (≥9 weeks vs 3–5. various facts support the study of covid-19 vaccine immunogenicity in people living with hiv (plwh) at this time: (1) many plwh in canada will be eligible to receive covid-19 vaccination as they are in a high priority risk group, such as residents or staff of shared living facilities for seniors, health care workers with direct patient contact,. Primary outcomes of the study included the rate of SARS-CoV-2 vaccination and the incidence of disease flares after vaccination. Of the 914 adults (92.5% women; mean age, 48.6±14.0 years) with SLE included in the analysis, 449 (49.1%) achieved full COVID-19 vaccination status. The majority (61.5%) of participants received 2 doses of. recommended COVID-19 vaccine, but have not received all recommended vaccine doses. References: 1. Use of At-Home COVID-19 Tests —United States, August 23, 2021–March 12, 2022 2. Stay Up to Date with Your COVID-19 Vaccines Additional resources: • Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status —. New public health data indicates age and vaccination were key factors in N.W.T. residents’ ability to combat COVID-19. The office of the chief public health officer released the data Tuesday. The European Medicines Agency (EMA) helps ensure that COVID-19 vaccines offer continued protection against the SARS-CoV-2 coronavirus, including variants such as Delta and Omicron, by working with European Union (EU) and international partners. United States: COVID-19 weekly death rate by vaccinationstatus. Death rates are calculated as the number of deaths in each group, divided by the total number of people in this group. This is. Vaccination coverage This page provides information on the number and percentage of people that have received a COVID-19 vaccine in Canada by province or territory, vaccination status, sex, age group, and vaccine series. We update this information every 4 weeks on Fridays at noon ET with data up to and including the previous Sunday. Presence or absence of preexisting condition was not reported for 404 pregnant women in the data which may have contributed to increased vulnerability to COVID-19 and hospitalization. Majority of this group of pregnant women were Latina or White. This circumstance could lead to underestimation of preexisting conditions. COVID-19 cases, severity, seriousness, outcomes, vaccination status, and breakthrough infection were evaluated. Results: As of 25 September 2021, 245 of 1703 patients (14.4%) enrolled in ALITHIOS receiving ofatumumab (median exposure: 2.45 years) reported COVID-19 (confirmed: 210; suspected: 35). For initial nonresponders to vaccination, seroconversion after a booster dose occurred in 48 of 85 patients (56%). The seroconversion rate after the booster was similar for patients on (53%) and off (58%) active therapy (p = .82). Thirty-three patients (8.8%) developed a COVID-19 infection, and there were three COVID-19–related deaths (0.8%). Since the beginning of the programme, Public Health England (PHE) has been monitoring the effectiveness of the vaccines in the real world as set out in the COVID-19 vaccine surveillance strategy. Common side effects of the COVID-19 vaccines include injection site pain, fatigue, headache, muscle pain and fever. Data from the Pfizer/BioNTech and Moderna trials also show the side effects.According to the CDC, anaphylaxis - a severe and possible life-threatening allergic reaction - occurs in 2 to 5 people per million vaccinated in the United States. This is a descriptive review of surveillance data on disparities in the risk and outcomes from COVID-19. The review looked at different factors including: age and sex where people live deprivation.

Click on the COVID-19 Vaccination Confirmation Form or use the QR code sent in email Log in using your MyCOM Portal username and password Complete the form by providing the type of vaccine and date Upload your proof of vaccination Read and review the Authorization for Use and Disclosure of Medical Information Acknowledge, sign, and submit. Blood neurofilament light chain (NFL) is proposed to serve as an estimate of disease severity in hospitalized patients with coronavirus disease 2019 (COVID-19). We show that NFL concentrations in plasma collected from 880 patients with COVID-19 within 5 days of hospital admission were elevated compa. This dataset reports the daily reported number of the 7-day moving average rates of Deaths involving COVID-19 by vaccination status and by age group. Learn how the Government of. In raw numbers, the vast majority of people testing positive for COVID-19, ending up in hospital, requiring critical care, and dying from COVID-19 in 2022, according to the dashboard, have been. Our World in Data also publishes data on COVID-19 fatality rates, in which low-income countries also experience worse outcomes. As of Oct. 2, the cumulative case fatality rate was 2.12% in low. Tracking Coronavirus Vaccinations Around the World. By Josh Holder Updated Sept. 4, 2022. 69.7% of the global population. Received at least one dose. Received additional dose. Fully vaccinated. In mid-September, King County, Washington, in which ­Seattle is located, released an eye-popping slide about vaccine efficacy and breakthrough prevalence: Vaccines had reduced the risk of infection. COVID-19 deaths by vaccination status in 50+ population Incidence # per mm 100 1,000 10,000 All participants No prior infection Prior infection Moderna booster Moderna Omicron booster Source: Moderna. June 25, 2022. Moderna booster vs Moderna Omicron booster efficacy Neutralizing antibody levels (log scale) 100 1,000 10,000 Original booster. "@ghurabaa_786 @stewardmogs @Poppyjuice @DrAseemMalhotra @InCytometry @SwaledaleMutton Then you have put yourself at vastly greater risk of a poor covid outcome than of a vaccine complication. This is a mistake.". this is evident in the public backlash that resulted from leaked proceedings of the north texas mass critical care guideline task force. 4 given that covid-19 vaccinations have unfortunately become heavily politicised, the more that healthcare institutions engage in practices that are—or are perceived to be—secretive, biased, discriminatory or. And how many were not vaccinated? Now we have all the information we need and can calculate the death rates: of 10 unvaccinated people, 5 died → the death rate among the. This new study, which the authors claim is the first to do so, investigated the relationship between COVID-19 vaccination status and survival outcomes among individuals with heart failure. Data Update Schedule. Our COVID-19 data is updated on these pages as follows: Daily data is updated every weekday.; Weekly data is updated every Thursday.; Monthly data is updated on the Monday following the 14th of each month.; More Information. About the Data | Data Glossary | Download the Data About Health Inequities in Data: Differences in health outcomes and. Background: The objective of this study was to assess changes in social and clinical determinants of COVID-19 outcomes associated with the first year of COVID-19 vaccination rollout in the Basque population. Methods: A retrospective study was performed using the complete database of the Basque Health Service (n = 2,343,858). We analyzed data on age,. There is evidence that vaccinated individuals who are infected with SARS-CoV-2 have lower viral loads than unvaccinated individuals, and COVID-19 vaccines are associated with a reduction in the number of SARS-CoV-2 infections not only among vaccinated individuals but also among their household contacts. 21-26. recommended COVID-19 vaccine, but have not received all recommended vaccine doses. References: 1. Use of At-Home COVID-19 Tests —United States, August 23, 2021–March 12, 2022 2. Stay Up to Date with Your COVID-19 Vaccines Additional resources: • Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status —. Data.CDC.gov. Search Search . Home Data Catalog Developers Video Guides. With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV. Background The temporal evolution of SARS-CoV-2 vaccine efficacy and effectiveness (VE) against infection, symptomatic, and severe COVID-19 is incompletely defined. The temporal evolution of VE could be dependent on age, vaccine types, variants of the virus, and geographic region. We aimed to conduct a systematic review and meta-analysis of the duration. Common side effects of the COVID-19 vaccines include injection site pain, fatigue, headache, muscle pain and fever. Data from the Pfizer/BioNTech and Moderna trials also show the side effects.According to the CDC, anaphylaxis - a severe and possible life-threatening allergic reaction - occurs in 2 to 5 people per million vaccinated in the United States. Post-vaccination cases are individuals who have a positive SARS-Cov-2 molecular test (e.g. PCR) at least 14 days after they have completed their primary vaccination series. Tracking cases of. On Nov. 9, 2020, New York-based Pfizer and the German company BioNTech made history by announcing that their coronavirus vaccine had an efficacy rate of over 90 percent, far surpassing. COVID-19 vaccination rates in hospitalized mentally ill patients compared to the general population in Germany: Results from the COVID Ψ Vac study - Volume 65 Issue 1 ... To determine risk factors of the outcome "vaccination status unvaccinated," a logistic regression with a multilevel random intercept model with "hospital site" as. Background The temporal evolution of SARS-CoV-2 vaccine efficacy and effectiveness (VE) against infection, symptomatic, and severe COVID-19 is incompletely defined. The temporal evolution of VE could be dependent on age, vaccine types, variants of the virus, and geographic region. We aimed to conduct a systematic review and meta-analysis of the duration. . COVID-19 Outcomes Achieved by the Vaccination Program: A Nationwide Cohort Study. Int. J ... sex, socioeconomic status, the Charlson comorbidity index (CCI), hospitalization and intensive care. Similar to the first trial, a single-center study by researchers at Hull Teaching Hospitals in England and published late last week in Clinical Infectious Diseases suggests that both symptomatic and asymptomatic COVID-19 infections fell as coronavirus vaccinations rose from 8.3% of hospital staff on Jan 4, 2021, to 82.5% by the week of Feb 22. Niagara Region Public Health statistics show 92.5 per cent of Niagara adults 18 and older have had a first dose of COVID-19 vaccine and 90.6 per cent have had a second dose. Third doses for adults. With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV. This is a descriptive review of surveillance data on disparities in the risk and outcomes from COVID-19. The review looked at different factors including: age and sex where people live deprivation. Get vaccinated – it’s safe, effective, and free. Vaccination is an important tool to end the COVID-19 pandemic. On this page: How to get vaccinated Who can get vaccinated How COVID-19 vaccines work Vaccines and variants Booster shots and additional doses Digital vaccine record Side effects Questions and answers How to get vaccinated: My []. protection against the most serious outcomes of COVID-19, increasing vaccination rates is key to limiting severe COVID-19 cases and saving lives. This report provides an overview of confirmed. In addition, it is difficult to interpret anti–COVID-19 seroconversion to clinical efficacy, nor can we know the required titer of neutralizing antibodies to confer clinical immunity. 7 Finally, the role of cellular immunity in COVID-19 infection is still unclear, with preliminary data suggesting abnormalities in these vulnerable patients. 22,23 All this information points to a. Combat COVID-19. You can help find ways to prevent and treat COVID-19—whether you’ve never had COVID-19, you have COVID-19 now, or you had it in the past. Learn how you can join a vaccine or treatment clinical trial, or donate your plasma to.

Background: The objective of this study was to assess changes in social and clinical determinants of COVID-19 outcomes associated with the first year of COVID-19 vaccination rollout in the Basque population. Methods: A retrospective study was performed using the complete database of the Basque Health Service (n = 2,343,858). We analyzed data on age,. Changes in non-COVID-19 mortality by vaccination status are largely driven by the changing composition of the vaccination status groups; this is because of the prioritisation of people. 1. BACKGROUND. Coronavirus disease 2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2 which was identified in December 2019 in Wuhan City, China, has resulted in a global pandemic with over 400 million cases worldwide ().COVID-19 has different presentations from mild flu like symptoms such as anosmia, dysgeusia, fever, sore throat, cough, dyspnea,. in the phase 3 trial of the mrna-1273/moderna vaccine, antibodies were assessed as a correlate for the risk of covid infection, with vaccine efficacy decreasing from 96% to 78% as the antibody levels dropped. 28 however, even with low humoral immunity, 77% of patients with hematologic malignancies who were infected with covid-19 had detectable. protection against the most serious outcomes of COVID-19, increasing vaccination rates is key to limiting severe COVID-19 cases and saving lives. This report provides an overview of confirmed. With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV. Risk factors associated with severe COVID-19 outcomes after receiving a booster dose were similar to those associated with worse outcomes after completion of the primary vaccination schedule. There was an increased risk of severe COVID-19 outcomes 9 weeks or more after receiving a booster dose of BNT162b2 or mRNA-1273 vaccine (≥9 weeks vs 3–5. COVID-19 vaccination status effective April 1, 2022. CMS is also implementing 7 new procedure codes to describe the introduction or infusion of therapeutics, including vaccines for COVID-19 treatment, into the ICD-10-PCS, effective April 01, 2022. CMS notes that for hospitalized patients, Medicare pays for COVID-19 vaccines and their. 1. BACKGROUND. Coronavirus disease 2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2 which was identified in December 2019 in Wuhan City, China, has resulted in a global pandemic with over 400 million cases worldwide ().COVID-19 has different presentations from mild flu like symptoms such as anosmia, dysgeusia, fever, sore throat, cough, dyspnea,. Let’s stop pretending the vaccines are 90% effective and breakthrough cases are “uncommon.”. The real world effectiveness of the Moderna and Pfizer (mRNA) vaccines appears to be sinking like a stone. We started at 94+% within 2 months of vaccination and against the original SARS-CoV-2 strain. B, Severe outcomes included hospitalization and death. Omicron vaccine effectiveness estimates for 7 to 59 days, 60 to 119 days, and 240 days or more after the second dose are not presented owing to imprecision in the estimates and wide 95% CIs (ie, ≥100 percentage points). Vaccination against Covid-19 reduces the risk of ... the same treatment or access to services resulting in different health outcomes. ... not had a fight about their respective vaccine status. COVID-19 vaccine dosage is based on age on the day of vaccination, not on size or weight. Children get a smaller dose of COVID-19 vaccine than teens and adults based on their age group. Pfizer-BioNTech Moderna Novavax Adults ages 18 years and older Pfizer-BioNTech Moderna Novavax Johnson & Johnson's Janssen. Clinical phenotype and vaccination background of Omicron vs Delta-infected patients. Compared to patients infected with variant Delta, those infected with variant Omicron were older and had. COVID-19 Cases and Deaths by Vaccination Status Dashboard Background To determine the effects of vaccination on COVID-19 cases and deaths in Texas, this dashboard describes COVID-19 outcomes among unvaccinated and vaccinated people in Texas using data from electronic lab reports, death certificates, and the state immunization registry. Background. By the end of April 2021, over 600 million individuals had received at least one dose of a coronavirus disease 2019 (COVID‐19) vaccine internationally. 1 This represents an extraordinary scientific and logistical achievement, where in around 12 months researchers, manufacturers and governments collaborated to produce and distribute vaccines. Plus, the level of immunity provided by the vaccines after having COVID-19 is higher than the level of immunity for those who had COVID but were not subsequently vaccinated. Getting vaccinated provides greater protection to others since the vaccine helps reduce the spread of COVID-19. this is evident in the public backlash that resulted from leaked proceedings of the north texas mass critical care guideline task force. 4 given that covid-19 vaccinations have unfortunately become heavily politicised, the more that healthcare institutions engage in practices that are—or are perceived to be—secretive, biased, discriminatory or. Key messages. In the current post-acute phase of the pandemic, the introduction and emergence of new SARS-CoV-2 variants with increased transmissibility and/or immune escape capacity, together with waning protection against infection and severe disease from natural or vaccine-induced immunity, can result in new waves of virus transmission and surges. One of the models that could be used to understand the adoption of vaccine uptake is the Health Belief Model (HBM). The aim of this study is to assess the role of HBM constructs and Perceived Health Status (PHS) on the vaccination status of individuals and to understand the role of socio-demographic variables on HBM scoring. A comparative cross-sectional telephone survey was. This dataset reports the daily reported number of the 7-day moving average rates of Deaths involving COVID-19 by vaccination status and by age group. Learn how the Government.